Used in research and development of therapies targeting Alzheimer’s disease by specifically binding to amyloid beta aggregates in the brain. Plays a key role in preclinical studies to evaluate the efficacy of amyloid clearance, serving as a reference standard in immunoassays and imaging techniques. Supports the calibration of diagnostic tools aimed at detecting amyloid plaque burden. Also utilized in comparative studies to assess performance of novel anti-amyloid antibodies in binding affinity and specificity.